Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP32865.RA6mnQsBO1uHsSJKmzkNqPOsaDPKquMt2pPZ1lWE68sdM130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32865.RA6mnQsBO1uHsSJKmzkNqPOsaDPKquMt2pPZ1lWE68sdM130_provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP17533.RAppJAnN4EeyXV7bRQ5-bX_nQFBjDylkT2fTX8LrjgTQw130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP17533.RAppJAnN4EeyXV7bRQ5-bX_nQFBjDylkT2fTX8LrjgTQw130_provenance.
• NP23639.RAk12CimigaZCm7vU9BUQR3jdiQau5hev-8gIf6_-5eOk130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23639.RAk12CimigaZCm7vU9BUQR3jdiQau5hev-8gIf6_-5eOk130_provenance.
• NP26835.RAtk-NRO03n4QGG_GAwrnMoBW7RIijCl_lYqqKjwdeLB4130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26835.RAtk-NRO03n4QGG_GAwrnMoBW7RIijCl_lYqqKjwdeLB4130_provenance.
• NP28798.RAYMyv1xaF2WO5Ii9H4Jfaf4-zmGJpogKk5s3jKEUBKdE130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28798.RAYMyv1xaF2WO5Ii9H4Jfaf4-zmGJpogKk5s3jKEUBKdE130_provenance.
• NP11418.RA6UDjVeeIJwuyN4AnboVMC2hsK7rICjkdSrJEE3pNSbs130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11418.RA6UDjVeeIJwuyN4AnboVMC2hsK7rICjkdSrJEE3pNSbs130_provenance.
• NP28802.RApSCsoFJ68u5JlKfPuTVIG75psJk9PazMHtxPg_Da--8130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28802.RApSCsoFJ68u5JlKfPuTVIG75psJk9PazMHtxPg_Da--8130_provenance.
• NP28815.RAh8X_jZZJRaOuTzDGcwGV1u_gQXUuPJzDtmFa0DA_bE4130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28815.RAh8X_jZZJRaOuTzDGcwGV1u_gQXUuPJzDtmFa0DA_bE4130_provenance.
• NP33709.RAhDxCK_odYO5CeAo9qokMmATUGOkWSAbD1R_pKbB8okc130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33709.RAhDxCK_odYO5CeAo9qokMmATUGOkWSAbD1R_pKbB8okc130_provenance.
• NP32828.RAFsHV4sJpx6Sw5gnBdnijLzgFdHMr01Hw24awb9qFEOA130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32828.RAFsHV4sJpx6Sw5gnBdnijLzgFdHMr01Hw24awb9qFEOA130_provenance.
• NP33693.RANp_8uXjqIt4cd79oFe2lY-qUhe6mtIJBZ5BH2RvFgB8130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33693.RANp_8uXjqIt4cd79oFe2lY-qUhe6mtIJBZ5BH2RvFgB8130_provenance.
• NP10522.RAodZ14hUEzKdIM8E_sMkTH_KOllW-XoNyXq4YtTb-RZg130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10522.RAodZ14hUEzKdIM8E_sMkTH_KOllW-XoNyXq4YtTb-RZg130_provenance.
• NP7673.RA0vivPOb32CW8cdS3ddKJi0TNznVcg-oWgn5NoM_7rUw130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7673.RA0vivPOb32CW8cdS3ddKJi0TNznVcg-oWgn5NoM_7rUw130_provenance.
• NP10770.RAO6ct8DX_-1-2-g-o5-6zQWdbxsYHG0Ub2-VSdUC6LP0130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10770.RAO6ct8DX_-1-2-g-o5-6zQWdbxsYHG0Ub2-VSdUC6LP0130_provenance.
• NP30725.RAHcHn27z-_s7CzsvPHBuPzh1oylyxZHMCHbu-NZpV7wE130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP30725.RAHcHn27z-_s7CzsvPHBuPzh1oylyxZHMCHbu-NZpV7wE130_provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP28889.RAeVOs0S80UDnfX94NdF-O_muQzYtb_eiQkAtyoVtFWGA130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28889.RAeVOs0S80UDnfX94NdF-O_muQzYtb_eiQkAtyoVtFWGA130_provenance.
• NP33320.RAbpwFHgxZbIcNA36dATY_K5sautxYmFkATQWTbC9paDs130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33320.RAbpwFHgxZbIcNA36dATY_K5sautxYmFkATQWTbC9paDs130_provenance.
• NP33360.RAZhKX-HLfBUCysaQSvleVxPUjkOfnLJ2ta1Qj_-XMMvk130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33360.RAZhKX-HLfBUCysaQSvleVxPUjkOfnLJ2ta1Qj_-XMMvk130_provenance.
• NP8966.RAYztfLu2e1ShzMvoGWJuNOSU2dErIPs2WCdFD63ty3Tc130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8966.RAYztfLu2e1ShzMvoGWJuNOSU2dErIPs2WCdFD63ty3Tc130_provenance.
• NP5850.RA5AoR7O1vZGdS6WrYFvchsjSZay5_7VH-DwSL40qkE7A130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP5850.RA5AoR7O1vZGdS6WrYFvchsjSZay5_7VH-DwSL40qkE7A130_provenance.
• NP26733.RAw6mpgEVX9NWzjUNK_TiaW4OyrwGV8r_KXM6GYrGARxU130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26733.RAw6mpgEVX9NWzjUNK_TiaW4OyrwGV8r_KXM6GYrGARxU130_provenance.
• NP16602.RAh8tmBMie16UmgShSVfaNWP1TxnJFCN9c0C7HJZAP6cA130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16602.RAh8tmBMie16UmgShSVfaNWP1TxnJFCN9c0C7HJZAP6cA130_provenance.
• NP28907.RA9GFmykGPTigsYC-UsRP21k6LujEm0UnaNDFnUrQDHos130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28907.RA9GFmykGPTigsYC-UsRP21k6LujEm0UnaNDFnUrQDHos130_provenance.
• NP34235.RA1NpTMyF29mNbg9WhG6QE8C6cvmbh4qavp0wVQOBT1PM130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP34235.RA1NpTMyF29mNbg9WhG6QE8C6cvmbh4qavp0wVQOBT1PM130_provenance.
• NP9938.RAhPFCPeL9Y46QjsgCajBSGu1tEH7N0FUvI69E7tlmxSo130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9938.RAhPFCPeL9Y46QjsgCajBSGu1tEH7N0FUvI69E7tlmxSo130_provenance.
• NP28894.RAphpPey6hvHfgxaWOsD8dlNm8lBmyPyRM1t8vryBIjUg130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28894.RAphpPey6hvHfgxaWOsD8dlNm8lBmyPyRM1t8vryBIjUg130_provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP21047.RAf5Rhpi55F9wdP3FWwN41kI2gVt4Ta1JISBgCiLOxusw130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21047.RAf5Rhpi55F9wdP3FWwN41kI2gVt4Ta1JISBgCiLOxusw130_provenance.
• NP21054.RAcOI7NsPoNGkaTje-9DxIhZltlLDLfyvA0L-JaWPONc8130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21054.RAcOI7NsPoNGkaTje-9DxIhZltlLDLfyvA0L-JaWPONc8130_provenance.
• NP21055.RAWZoq7BIZ_sw_3ko7I_dvXczU3qXcIlp19wUxzgf20t4130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21055.RAWZoq7BIZ_sw_3ko7I_dvXczU3qXcIlp19wUxzgf20t4130_provenance.
• NP21056.RASh0TuQhcxHgoJFDWNaosO-JQZL8HMXwASLMEG4KzREo130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21056.RASh0TuQhcxHgoJFDWNaosO-JQZL8HMXwASLMEG4KzREo130_provenance.
• NP21058.RAeUOxUCKMP7zRDxO0ueq13EiY6vOgcN5DhkcQvXkH2-w130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21058.RAeUOxUCKMP7zRDxO0ueq13EiY6vOgcN5DhkcQvXkH2-w130_provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP23274.RAExUppghuQUJI99s1S2hqovX9ezH_n8ek295LbSkSjtw130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23274.RAExUppghuQUJI99s1S2hqovX9ezH_n8ek295LbSkSjtw130_provenance.
• assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP30984.RAODKiOHd4FrETDNr5jBgmVOS3Jklmpf7kRyPCFPxi7qE130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP30984.RAODKiOHd4FrETDNr5jBgmVOS3Jklmpf7kRyPCFPxi7qE130_provenance.
• NP34252.RAL27F5OcmgdV5El1vQo0A5UsgQWfrJp5oVIq20RFcPhE130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP34252.RAL27F5OcmgdV5El1vQo0A5UsgQWfrJp5oVIq20RFcPhE130_provenance.
• NP9230.RAK7BgZLYCCsbO-LJD1L6ipST1YpSOojWshFHTP158y7w130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9230.RAK7BgZLYCCsbO-LJD1L6ipST1YpSOojWshFHTP158y7w130_provenance.
• NP21048.RAn2hpw4vF68KxeeiO_bkjQfB7aG8BfPtkV4p0m6DtTic130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21048.RAn2hpw4vF68KxeeiO_bkjQfB7aG8BfPtkV4p0m6DtTic130_provenance.
• NP21049.RAuvXKnkKkGjh7J_ePkZSnk1Qv_iy9MUX2IWx6pN8aDEc130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21049.RAuvXKnkKkGjh7J_ePkZSnk1Qv_iy9MUX2IWx6pN8aDEc130_provenance.
• NP21053.RAkRuXvTnePiktKf36wj446ETxI34RGAcgjA-rhlmdvfM130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21053.RAkRuXvTnePiktKf36wj446ETxI34RGAcgjA-rhlmdvfM130_provenance.
• NP21059.RAr26cnYE_jhbM9TwRdjjrFwfJ-a8soYQJsfl3hZnAp08130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21059.RAr26cnYE_jhbM9TwRdjjrFwfJ-a8soYQJsfl3hZnAp08130_provenance.
• NP21050.RA2JQXxsJ8C8-zmbClRl6Y3moLOeip_Xjyo7iCTjoWhlg130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21050.RA2JQXxsJ8C8-zmbClRl6Y3moLOeip_Xjyo7iCTjoWhlg130_provenance.
• NP21052.RALex_d_XqZIYOy3u0EJOukz2Tpldf3IGIeNKlnovZItw130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21052.RALex_d_XqZIYOy3u0EJOukz2Tpldf3IGIeNKlnovZItw130_provenance.
• NP21057.RAOYuTn6-AcreUDijeWHrTovuTvnySx4SA8ZTGQ2ORy5o130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21057.RAOYuTn6-AcreUDijeWHrTovuTvnySx4SA8ZTGQ2ORy5o130_provenance.
• NP21046.RA-P7Z_MO-wvuh0Qka20XzZkeWL7iLo5d1F1LoBwa0ZYI130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21046.RA-P7Z_MO-wvuh0Qka20XzZkeWL7iLo5d1F1LoBwa0ZYI130_provenance.
• NP21051.RA9hHEV3KGFar8mbNo8On22SCQDQ8W7FkDw8rL5cFPWN0130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21051.RA9hHEV3KGFar8mbNo8On22SCQDQ8W7FkDw8rL5cFPWN0130_provenance.
• NP21060.RAzxd7BMkFy7nDPxb-9eprs07bhczFAgY0pSF4M6NWloA130_assertion description "[Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21060.RAzxd7BMkFy7nDPxb-9eprs07bhczFAgY0pSF4M6NWloA130_provenance.